2010
PLAGL2 regulates Wnt signaling to impede differentiation in neural stem cells and gliomas. Cancer Cell. 2010;17(5):497-509.
Pathologic classification of diabetic nephropathy. J Am Soc Nephrol. 2010;21(4):556-63.
Risk factors for clinical manifestations in carriers of Factor V Leiden and prothrombin gene mutations. Blood Coagul Fibrinolysis. 2010;21(1):11-5.
Fatty acid synthase as a potential therapeutic target in cancer. Future Oncol. 2010;6(4):551-62.
NBR1 is a new PB1 signalling adapter in Th2 differentiation and allergic airway inflammation in vivo. EMBO J. 2010;29(19):3421-33.
Renal epithelioid angiomyolipoma with atypia: a series of 40 cases with emphasis on clinicopathologic prognostic indicators of malignancy. Am J Surg Pathol. 2010;34(5):715-22.
Conflicts of interest, authorship, and disclosures in industry-related scientific publications. Mayo Clin Proc. 2010;85(2):197-9; author reply 201-4.
BLIMP1 is a tumor suppressor gene frequently disrupted in activated B cell-like diffuse large B cell lymphoma. Cancer Cell. 2010;18(6):568-79.
The histone shuffle: histone chaperones in an energetic dance. Trends Biochem Sci. 2010;35(9):476-89.
Gammopathy-associated acrosclerosis as a cause of flexion contractures in an older adult patient: a case report and literature review. Adv Skin Wound Care. 2010;23(1):25-8.